COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 784: Articles 7831-7840  | Next

Impact of non-pharmaceutical interventions targeted at the COVID-19 pandemic on influenza cases in the UK Armed Forces
Niba Rawlings, N., Otieno, G.
10.1101/2022.06.12.22276290 — Posted: 2022-06-14
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study
Beale, S., Burns, R., Braithwaite, I., Byrne, T. E., Fong, W. L. E., Fragaszy, E., Geismar, C., Hoskins, S. J., Kovar, J., Navaratnam, A. M. D., Patel, P., Yavlinsky, A., Van Tongeren, M. J., Aldridge, R. W., Hayward, A.
10.1101/2022.06.12.22276307 — Posted: 2022-06-13
Patterns of Reported Infection and Reinfection of SARS-CoV-2 in England
Keeling, M. J.
10.1101/2022.06.13.22276316 — Posted: 2022-06-13
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)
Munoz, F. M., Posavad, C. M., Richardson, B. A., Badell, M. L., Bunge, K., Mulligan, M. J., Parameswaran, L., Kelly, C., Olson-Chen, C., Novak, R. M., Brady, R. C., Pasetti, M., DeFranco, E., Gerber, J. S., Shriver, M., Suthar, M. S., Moore, K., Coler, R., Berube, B., Kim, S. H., Piper, J. M., Miller, A., Cardemil, C., Neuzil, K. M., Beigi, R., DMID Study Group
10.1101/2022.06.13.22276354 — Posted: 2022-06-13
Alterations in the Nasopharyngeal Microbiome Associated with SARS-CoV-2 Infection Status and Disease Severity
Gauthier, N. P. G., Locher, K., MacDonald, C., Chorlton, S. D., Charles, M., Manges, A. R.
10.1101/2022.06.13.22276358 — Posted: 2022-06-13
Structure of SARS-CoV-2 M protein in lipid nanodiscs
Dolan, K. A., Dutta, M., Kern, D. M., Kotecha, A., Voth, G. A., Brohawn, S. G.
10.1101/2022.06.12.495841 — Posted: 2022-06-13
Dynamics of SARS-CoV-2 genetic mutations and their information entropy
Vopson, M. M.
10.1101/2022.06.13.495895 — Posted: 2022-06-13
SARS2Mutant: SARS-CoV-2 Amino-Acid Mutation Atlas Database
Rahimian, K., Mahmanzar, M., Mahdavi, B., Arefian, E., Kuehu, D. L., Deng, Y.
10.1101/2022.06.12.495856 — Posted: 2022-06-13
Accurate and Fast Clade Assignment via Deep Learning and Frequency Chaos Game Representation
Avila Cartes, J., Anand, S., Ciccolella, S., Bonizzoni, P., Della Vedova, G.
10.1101/2022.06.13.495912 — Posted: 2022-06-13
An attenuated vaccinia vaccine encoding the SARS-CoV-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human ACE2 transgenic mice from SARS-CoV-2 and its variants
Ishigaki, H., Yasui, F., Nakayama, M., Endo, A., Yamamoto, N., Yamaji, K., Nguyen, C. T., Kitagawa, Y., Sanada, T., Honda, T., Munakata, T., Higa, M., Toyama, S., Kono, R., Takagi, A., Matsumoto, Y., Hayashi, K., Shiohara, M., Ishii, K., Saeki, Y., Itoh, Y., Kohara, M.
10.1101/2022.06.12.495779 — Posted: 2022-06-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).